Dieter Hoelzer

Goethe University Frankfurt — Germany

Medicine · Health Sciences

79h-index28.4kcitations474works41.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(217), Chronic Myeloid Leukemia Treatments(148), Acute Myeloid Leukemia Research(131), Chronic Lymphocytic Leukemia Research(113), Lymphoma Diagnosis and Treatment(84)

Publications473 total

Matched unrelated vs. Haploidentical  donor for allogeneic stem cell transplantation in patients with acute leukemia with identical GvHD prophylaxis – a randomized prospective european trial.
Blood·2025
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet
The Lancet Haematology·2025· 6 citedOpen Access
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
Blood·2024· 92 citedOpen Access
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
Blood·2024· 69 citedOpen Access
Prognostic Markers and Models in Acute Lymphoblastic Leukemia
2023Open Access
Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment
Scientific Reports·2023· 10 citedOpen Access
S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
HemaSphere·2023Open Access
Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review
Leukemia & lymphoma/Leukemia and lymphoma·2023· 19 cited
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia
Haematologica·2023· 7 citedOpen Access
Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia
Blood Reviews·2023· 13 cited
Editorial Board
Clinical Lymphoma Myeloma & Leukemia·2022Open Access
Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols
Blood·2022· 17 cited
Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia
Transplantation and Cellular Therapy·2022· 12 citedOpen Access
Publisher Correction: Rolf Neth (October 6, 1926–March 17, 2020)
Leukemia·2021Open Access
Chemotherapy-free Treatment — A New Era in Acute Lymphoblastic Leukemia?
New England Journal of Medicine·2020· 11 cited
Rolf Neth (October 6, 1926 to March 17, 2020)
Leukemia·2020· 3 citedOpen Access
Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial
Hematological Oncology·2020· 25 citedOpen Access
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
ESMO Open·2020· 40 citedOpen Access
Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia
European Journal Of Haematology·2019· 22 citedOpen Access
Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers
JAMA Oncology·2019· 107 citedOpen Access
page 1 of 24Next →

Frequent Co-authors

Nicola Gökbuget(19), Oliver G. Ottmann(13), Monika Brüggemann(10), Matthias Stelljes(8), Michael Kneba(8), Gerhard Heil(7), Andreas Viardot(7), Arnold Ganser(7), Thorsten Raff(6), Roman Pfeifer(6), Heinz‐August Horst(6), Eckhard Thiel(6), Stefan Schwartz(6), Georg Maschmeyer(5), Barbara Waßmann(5), Markus Schaich(5), Gesine Bug(5), Mathias Rummel(4), Dorothea Kofahl-Krause(4), Svenja Neumann(4)